BBPvsXHEETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. State Street SPDR S&P Health Care Equipment ETF (XHE) is part of the US Health Care segment. BBP's top 1 sector exposures are Healthcare. In contrast, XHE's top sector exposures are Healthcare and Finance. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.35% for XHE. BBP is up 28.37% year-to-date (YTD) with +$66M in YTD flows. XHE performs worse with 5.47% YTD performance, and -$11M in YTD flows. Run a side-by-side ETF comparison of BBP and XHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs XHE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/26/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP XHE | -2.65%+1.46% | +5.62%+6.27% | +28.37%+5.47% | +38.01%+13.71% | +119.28%+39.01% | +100.33%-25.84% |
| Flows | BBP XHE | --$43M | +$26M-$13M | +$66M-$11M | +$78M-$15M | +$83M-$225M | +$76M-$401M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP XHE | +28.32%+20.52% | +26.44%+22.75% | +24.98%+21.88% | +26.86%+24.86% |
| Max drawdown | BBP XHE | -8.70%-9.09% | -9.59%-18.20% | -25.54%-24.35% | -37.61%-49.37% |
| Max drawdown duration | BBP XHE | 68d68d | 48d207d | 292d565d | 586d1818d |
Trading data
BBP | XHE | |
Last sale 10/27/2026 at 1:30 PM | $104.89 | $93.25 |
| Previous close 10/26/2026 | $102.33 | $93.09 |
| Consolidated volume 10/26/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | XHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/27/2026 at 1:30 PM
Live
Closed
BBP | XHE | |
|---|---|---|
| Last price | $104.89 | $93.25 |
| 1D performance | +2.50% | +0.17% |
| AuM | $127.99 M | $151.04 M |
| E/R | 0.34% | 0.35% |
Characteristics
BBP | XHE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | State Street Investment Management |
| Benchmark | LifeSci Biotechnology Products Index | S&P Health Care Equipment Select Industry Index |
| N° of holdings | 66 | 67 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | January 26, 2011 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
85.98%
Other
14.02%
XHE
USA
93.57%
Other
6.43%
Sectors
BBP
Healthcare
98.44%
Other
1.56%
XHE
Healthcare
97.47%
Other
2.53%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
31.08%
XHE
Total weight of top 15 holdings out of 15
30.96%
Top 15 holdings
Data as of August 31, 2026
BBP
Moderna, Inc.
3.58%
Crinetics Pharmaceuticals, Inc.
2.94%
Omeros Corp.
2.49%
Iovance Biotherapeutics, Inc.
2.36%
Verastem, Inc.
2.15%
Precigen, Inc.
1.99%
Halozyme Therapeutics, Inc.
1.84%
Zai Lab Ltd.
1.82%
Kiniksa Pharmaceuticals International Plc
1.81%
Kura Oncology, Inc.
1.72%
BeOne Medicines Ltd.
1.70%
Rigel Pharmaceuticals, Inc.
1.69%
Nuvation Bio, Inc.
1.69%
ACADIA Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
XHE
AtriCure, Inc.
2.59%
Strive, Inc. (United States)
2.47%
Inspire Medical Systems, Inc.
2.19%
Glaukos Corp.
2.16%
Butterfly Network, Inc.
2.15%
CONMED Corp.
2.02%
Integer Holdings Corp.
2.02%
Tandem Diabetes Care, Inc.
2.00%
Merit Medical Systems, Inc.
1.99%
Artivion, Inc.
1.94%
Haemonetics Corp.
1.93%
UFP Technologies, Inc.
1.89%
Baxter International, Inc.
1.88%
Becton, Dickinson & Co.
1.87%
Neogen Corp.
1.86%
Frequently asked questions about BBP and XHE
How have the BBP and XHE ETFs performed in 2026?
As of October 26, 2026, BBP is up 28.37% year-to-date (YTD), while XHE has returned 5.47%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or XHE?
Year-to-date, the BBP ETF saw +$66M in flows, compared to -$11M for XHE.
Which ETF is more volatile: BBP or XHE?
Over the past year, BBP had a volatility of 26.44%, while XHE experienced 22.75%.
Which ETF is bigger: BBP or XHE?
As of October 26, 2026, BBP holds $127.99 M in assets under management (AUM), while XHE manages $151.04 M.
What sectors do the BBP and XHE ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, XHE focuses on Healthcare.
What are the top holdings of the BBP ETF and XHE ETF?
BBP top holdings include Moderna, Inc., Crinetics Pharmaceuticals, Inc. and Omeros Corp.. XHE holds in its top three: AtriCure, Inc., Strive, Inc. (United States) and Inspire Medical Systems, Inc..
Which ETF is more diversified: BBP or XHE?
BBP holds 66 securities with 31.08% of its assets in the top 15. XHE has 67 securities and a top 15 weight of 30.96%.
Advertisement
Advertisement
